Rivus Pharmaceuticals’ $132 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal.Rivus Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now